Signal One in six US households tried GLP-1s by July 2024 and cut grocery spend about 6%

Summary

McKinsey highlights how quickly GLP-1 medications are spreading and how they affect household spending. Citing Cornell research, it reports that roughly one in six US households had at least one member who had tried GLP-1s as of July 2024. Those households cut grocery spending by about 6 percent within six months of starting the drugs. However, 34 percent of users stopped taking them within six months and, on average, went back to their previous spending levels. With projections that 25 million Americans could be on GLP-1 treatment by 2030, the report sees these drugs as a growing force in food demand and in related categories.